Check out your Company Bowl for anonymous work chats.
What is the key to a successful application? Whether you're a seasoned professional or a fresh graduate, with these tips from our recruitment specialists around the globe, you'll be well-equipped for the job application process. From creating a compelling resume to nailing your interview - they’ve covered it all. Read more recommendations on the Sartorius blog: https://sar.to/application-tips Or head directly to our open jobs: www.sartorius.com/jobs
Simplifying Plasmid DNA Production Plasmid DNA (pDNA) can be used as a vaccine itself as well as for the development of gene therapies or mRNA vaccines. However, its production is challenging. A critical step, alkaline cell lysis, uses an alkaline solution to break up cell walls and release pDNA. Filling a gap on the market, the Sartorius team in Slovenia developed a fully automated system for reliable and scalable alkaline lysis. The Alkalizator gives users precise control over the alkaline process, resulting in higher efficiency and quality of the pDNA. Dr. Matevž Korenč, Product Manager and member of the development team: "This optimization directly reduces the production costs, making the development of therapies for rare genetic diseases more attractive to biopharma companies – and treatments ultimately more affordable for patients." Dive into the full story on the Sartorius blog and learn more about how the team addresses a pain point in downstream processing: https://sar.to/1bwiw
Together with its long-term partners, Sartorius is shaping the economic and social environment around its global sites. 🌐 We not only want to be a good corporate citizen and make a positive impact outside the company, but also aim to foster social sustainability, for example diversity and inclusion, in our own teams. 🌈 In 2024, we continued our support for community projects near our sites, promoted life science education and helped to improve pharmaceutical training in Africa. Discover more about these initiatives and further efforts: ➡️ Sartorius Employees in France Participate in Charity Runs Against Cancer: https://sar.to/merze ➡️ Shaping an Inclusive and Diverse Culture: Sartorius’ Employee Resource Groups: https://sar.to/pu2eu ➡️ Science Journalist Wins LifeScienceXplained 2024: https://sar.to/199qe ➡️ Partnering for Better Health: Empowering Pharmaceutical Training in East Africa: https://sar.to/w3abq
At Sartorius, we aim to contribute to better medical care for people around the world. Thus, sustainability is at the heart of what we do. As a signee to the United Nations Global Compact, we are also committed to sustainability principles, including reducing the impact of our business on the environment. 🌏 We have set ambitious goals and together with our customers and suppliers, aim to achieve net zero emissions by 2045.🏁🔄 As we wrap up the year, explore some of our activities aimed at reducing our impact in areas such as climate, materials and circularity as well as water: ➡️ Leaping Into Climate-Neutral Heating and Cooling: https://sar.to/1np75 ➡️ On the Way to Circularity: https://sar.to/bstbr ➡️ Every Drop of Water Counts: https://sar.to/79mfl ➡️ Sartorius and Covestro Prove the Recycling Potential of Small-Scale Bioreactors: https://sar.to/11lv2
In 2024, our team of around 14,000 creative minds, life science enthusiasts, and risk takers continued to work towards a common ambition: better health for more people.💉🌐 Our people are #pioneers, who help advance life sciences to make new therapies a reality.💛 Meet some of them, and learn how they drive progress in our industry as well as in their own careers: ➡️ Pioneering Work for Cell and Gene Therapies: Felicia Rosenthal: https://sar.to/f3ipq ➡️ Leading at a Young Age: Faten Belhadj Amor: https://sar.to/aqocc ➡️ Ensuring Patient Safety in Vaccine Production: Hovery Yin: https://sar.to/6kpsd ➡️ Speaking Up for Her Ambitions: Daniela Katarzynski: https://sar.to/udyms ➡️ New CEO as of July 1, 2025: Michael Grosse: https://sar.to/kcbxs
Discover what was going on at Sartorius sites around the globe in 2024 ✨🌏 This year we completed two construction projects in the U.S. and celebrated a special anniversary at the company’s hometown of Göttingen.🏗️ As the year approaches its end, let’s recap facility openings in Ann Arbor and Marlborough, U.S., get an overview about our site in Bangalore, India and go on a journey with us back to the beginnings of the Campus in Göttingen, Germany: ➡️ Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor: https://sar.to/igt1m ➡️ Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA: https://sar.to/yvq81 ➡️ This is Sartorius Bangalore: Biopharmaceutical Engineering and Manufacturing: https://sar.to/7eveh ➡️ Back to the 80s: Setting the Stage for Today’s Campus: https://sar.to/ivz5p
🌍 Partnering for Better Health: Empowering Communities in East Africa 🌟 As part of its “Donations instead of Gifts” initiative, Sartorius is supporting the IMPACT project this year. Run by our long-term partner action medeor e.V., the project is dedicated to improving pharmaceutical knowledge and access to high-quality medicines in rural areas of Kenya, Tanzania, and Rwanda. In many regions of East Africa, a shortage of trained professionals limits the availability of safe and effective medicines. The IMPACT project tackles these issues by: ✅ Training 120 healthcare workers across 53 facilities. ✅ Enabling 9 master trainers to expand knowledge and skills throughout the region. With this, the project aims to ensure patients receive the right medicines in the right dosage at the right time and empower communities to manage treatments effectively on their own.
At Sartorius, we empower scientists and engineers to simplify and accelerate progress in lifescience and bioprocessing, enabling the development of new and better therapies and more affordable medicine. Together, let’s look back at the year 2024 and explore how Sartorius is part of the solution and how we drive innovation to create better health for more people: - Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery: https://sar.to/nhcrs - Sartorius Collaborates With Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification: https://sar.to/uy74a - Overcoming Animal Testing with Advanced Cell Models: https://sar.to/z3qxk - Sartorius to Advance Drug Discovery and Manufacturing With AI in Collaboration With NVIDIA: https://sar.to/nu5xd - How Purification Experts Make Novel Drugs Safe for Use: https://sar.to/9jjm5
How purification experts make novel drugs safe for use with a “super-effective sponge” Before life-saving vaccines and novel treatments like gene therapies can reach patients, they must meet the highest standards of purity. This means removing impurities, such as residual proteins, DNA or media, through complex, time-consuming purification processes like filtration and chromatography. For large molecules, this is particularly challenging. That’s where Sartorius BIA Separations in Slovenia comes in. The team of experts develops innovative technologies, including what they call a “super-efficient sponge”, to simplify the purification of such large molecules. Separating right from wrong quickly and efficiently, they help customers achieve the purity needed to get new treatments to the market. Discover more on the Sartorius Blog about how they are part of the solution in making safe, effective medications a reality for patients: https://sar.to/ch9gf
As of July 1, 2025, Michael Grosse will succeed Joachim Kreuzburg as CEO of Sartorius AG At its meeting today, the Supervisory Board of Sartorius AG appointed Dr. Michael Grosse Chief Executive Officer of Sartorius. He will take over this position on July 1, 2025, from Dr. Joachim Kreuzburg, who will continue to lead the company until that time. The appointment is the result of a selection process that started in the summer of 2024, after Kreuzburg had announced that, after more than two decades as CEO, he would not seek another renewal of his contract, which expires in November 2025. The Chairman of the Supervisory Board, Dr. Lothar Kappich, commented: ”Michael Grosse has impressively demonstrated his operational and strategic skills across a range of industries and business models, and his openness, persistence and focus on results are an excellent match with the Sartorius culture. I am now very much looking forward to working together with Mr. Kreuzburg and our successful Executive Board for another six months, and then to welcoming Mr. Grosse to Sartorius next July.”
